AbbVie to Host Second-Quarter 2025 Earnings Conference Call
AbbVie (NYSE: ABBV) has scheduled its second-quarter 2025 financial results announcement for Thursday, July 31, 2025, before market opening. The company will host a live earnings conference call at 8 a.m. Central time. Investors can access the webcast through AbbVie's Investor Relations website at investors.abbvie.com, with an archived version available later that day.
AbbVie (NYSE: ABBV) ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per gioved矛 31 luglio 2025, prima dell'apertura dei mercati. La societ脿 terr脿 una conference call in diretta sui risultati alle 8:00 ora centrale. Gli investitori potranno seguire la trasmissione in streaming sul sito delle Relazioni con gli Investitori di AbbVie all'indirizzo investors.abbvie.com, con una versione registrata disponibile pi霉 tardi nella giornata.
AbbVie (NYSE: ABBV) ha programado el anuncio de sus resultados financieros del segundo trimestre de 2025 para el jueves 31 de julio de 2025, antes de la apertura del mercado. La empresa realizar谩 una conferencia telef贸nica en vivo sobre las ganancias a las 8 a.m., hora central. Los inversores pueden acceder a la transmisi贸n en vivo a trav茅s del sitio web de Relaciones con Inversores de AbbVie en investors.abbvie.com, con una versi贸n archivada disponible m谩s tarde ese mismo d铆a.
AbbVie (NYSE: ABBV)電� 2025雲� 2攵勱赴 鞛 鞁れ爜 氚滍憸毳� 2025雲� 7鞗� 31鞚� 氇╈殧鞚�, 鞁滌灔 臧滌灔 鞝勳溂搿� 鞓堨爼頄堨姷雼堧嫟. 須岇偓電� 欷戨秬 鞁滉皠 鞓れ爠 8鞁�鞐� 鞁れ爜 甏�霠� 霛检澊敫� 旎嵓霟办姢 旖滌潉 歆勴枆頃� 鞓堨爼鞛呺媹雼�. 韴瀽鞛愲摛鞚� AbbVie 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼 investors.abbvie.com鞚� 韱淀暣 鞗轨簮鞀ろ姼鞐� 鞝戩啀頃� 靾� 鞛堨溂氅�, 臧欖潃 雮� 雮橃鞐� 雲鬼檾氤鸽弰 鞝滉车霅╇媹雼�.
AbbVie (NYSE : ABBV) a pr茅vu d鈥檃nnoncer ses r茅sultats financiers du deuxi猫me trimestre 2025 le jeudi 31 juillet 2025, avant l鈥檕uverture des march茅s. La soci茅t茅 organisera une conf茅rence t茅l茅phonique en direct sur les r茅sultats 脿 8 heures, heure centrale. Les investisseurs pourront acc茅der 脿 la webdiffusion via le site des relations investisseurs d鈥橝bbVie 脿 l鈥檃dresse investors.abbvie.com, avec une version enregistr茅e disponible plus tard dans la journ茅e.
AbbVie (NYSE: ABBV) hat die Bekanntgabe der Finanzergebnisse f眉r das zweite Quartal 2025 f眉r Donnerstag, den 31. Juli 2025, vor B枚rsen枚ffnung geplant. Das Unternehmen wird um 8 Uhr Central Time eine Live-Konferenzschaltung zur Ergebnisbesprechung abhalten. Investoren k枚nnen den Webcast 眉ber die Investor-Relations-Website von AbbVie unter investors.abbvie.com verfolgen; eine Aufzeichnung wird sp盲ter am Tag verf眉gbar sein.
- None.
- None.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas 鈥� immunology, oncology, neuroscience, and eye care 鈥� and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at . Follow @abbvie on 听, , , and 听
Media: Gabby Tarbert听 听 | Investors: Liz Shea |
View original content to download multimedia:
SOURCE AbbVie
FAQ
When will AbbVie (ABBV) report Q2 2025 earnings?
What time is AbbVie's Q2 2025 earnings conference call?
How can investors access AbbVie's Q2 2025 earnings call?
Will AbbVie's Q2 2025 earnings call be available for replay?
